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Failure of SAMe-ST to counteract CCI4-induced reduction of radio active leucine incorporation into the trichloroacetic acid-insoluble materials in hepatocytes indicates that the observed effects of SAMe-ST or L-Met do not involve acceleration of protein synthesis.
The present results indicate that SAMe ST remarkably protects hepatocytes from CCI4-induced hepatotoxicity, probably by either changing the structure or compositions of membrane phospholipids or by modifying the interaction of CCI4 with the intracellular drug-metabolizing enzyme systems.
It is well established that S-adenosy!-L methionine (SAMe) is important in many biochemical processes: for example, as a main methyl donor for the transmethylation reaction in biological systems (1, 2) .
Our recent study has shown that SAMe disulfate tosylate (SAMe-ST) exerts an in hibitive effect on enzyme leakage from cultured rat hepatocytes and hypotonic hemol ysis (3) . Also, the preventive effect of SAMe on ethinyl estradiol (EE)-induced impairment of bile flow was observed by other authors (4, 5) , who speculated that this effect was prob ably accompanied by a decrease in EE bind ing to liver microsomal proteins. Furthermore, remarkably effective protection by SAMe against hepatotoxicity caused by acetamino phen (6), CCI4 (7) or D-galactosamine (8) has been reported. The precise mechanism of the protective effect of SAMe against these types of hepatotoxicity is not yet clear. Pos sible explanations for this protection include a mechanism involving the transmethylation activity of SAMe (9) and an increase in mem brane fluidity and metabolic rate of membrane phospholipids induced by SAMe (10). To obtain further information about the mech anisms by which SAMe-ST protects against CCI4-induced hepatotoxicity, the present study was performed to compare the effects of SAMe-ST with the effects of L-methionine (L-Met), a precursor of SAMe, in cultured hepatocytes. GPT (160.0% compared with the control) leaked from the cultured hepatocytes. This is consistent with our previous findings (15) that leakage of these two enzymes is observed in the presence of as low as 5 mM CC14 in the WE medium. In the cultured hepatocytes treated with SAMe-ST and 5 mM CC14, GOT and GPT leakage decreased about 50% as compared to 5 mM CC14 alone. In the treat ment with L-Met and 5 mM CC14, GOT leakage decreased 20-30% and GPT leakage about 50% as compared to 5 mM CC14 alone.
Materials and Methods
As shown in Fig. 3 , the secretion of urea-N from the cultured hepatocytes exposed to 5 MM CC14 was significantly less than that from the control (54.8% compared with the con trol). The urea-N secretion after treatment with SAMe-ST at a concentration of 0.1 or 0.5 mg/ml and 5 mM CC14 significantly in creased compared with that in hepatocytes treated with 5 mM CCI4 alone. On the other hand, L-Met did not prevent the decrease in urea-N secretion caused by the treatment with 5 mM CCI4.
The effects of SAMe-ST and L-Met on the incorporation of 14C-leucine into the TCA insoluble materials in the cultured hepatocytes are shown in Fig. 4 . The radioactivity in cultured hepatocytes treated with 5 mM CCI4 alone was significantly decreased, while SAMe-ST did not protect against the radio activity decrease caused by 5 mM CCI4 treatment. In addition, the radioactivity in the cultured hepatocytes treated with both 1.0 mg/ml L-Met and 5 mM CCI4 significantly decreased compared with those treated with 5 mM CCI4 alone. The amount of radioactivity in the materials in hepatocytes treated with SAMe-ST or L-Met alone did not differ from that in the control (data not shown).
After treatment with SAMe-ST or L-Met, the morphology of cultured hepatocytes was observed by phase contrast microscopy. The cultured hepatocytes of the three groups, i.e., the control, cells treated with SAMe-ST and cells treated with L-Met, resembled the morphology of normal hepatocytes in vivo; and there was no distinct differences among the morphologies of the three preparations (data not shown). The hepatocytes treated with 5 mM CCI4, however, showed many nonviable cells, but those treated with CCI4 and SAMe-ST revealed fewer nonviable cells (Fig. 5) .
Discussion
In the present study, SAMe-ST showed protective effects against CCI4-induced acute hepatotoxicity, as judged by the decrease in leakage of GOT and GPT. L-Met also showed similar protective effects but only to a lesser degree than SAMe, and these effects were The minimal effect of SAMe or L-Met on the rate of intracellular protein synthesis, as fudged by the amount of accumulated radio active leucine, supports the idea that there is no direct interaction of these compounds with the biosynthesis of intracellular proteins, in cluding various enzyme proteins. When the cultured hepatocytes were treated with 5 mM CCI4 and SAMe-ST, the secretion of urea-N from hepatocytes increased at lower concen tration and decreased at high concentration of SAMe-ST compared with those treated with 5 mM CCI4 alone. Tanaka and Ichihara (24) proposed a model of two compartments of amino acids in hepatocytes. One of them is supplied by lysosomal degradation of protein and used mainly for the synthesis of intracel lular protein. The other is supplied from ex ogenous amino acids and used for synthesis of both intra and extracellular proteins. How ever, excess amino acids added in the medium were used mainly for synthesis of intra and extracellular protein, and few were supplied by lysosomal degradation of protein. There fore, we considered that the secretion of urea N as final metabolites using intracellular pro tein did not increase when the cultured hepa tocytes were treated with SAMe-ST at 1.0 mg/ml (1.30 mM) or L-Met (0.67-6.7 mM).
All data presented here suggest that hepa totoxicity induced by CC14 was remarkably prevented by SAMe-ST and to a lesser extent by L-Met. Although the mechanisms of action of these compounds are unclear at present, the hepatic microsomal membranes and/or the drug-metabolizing enzyme system is most likely to be the primary site(s) for the pro tective action SAMe-ST. Further studies are underway in our laboratory to clarify the precise mechanism(s) of action of these com pounds on the hepatocytes.
